CARLSBAD, CA--(Marketwire - June 02, 2009) -
Applied Nanoscience Inc. (ANI) (PINKSHEETS: APNN
), a nanotechnology-based filtration development company, today
announced it has received formal notification for the issuance of four
patents in Mexico for its broad IP platform encompassing "Filtering Devices
Incorporating Nanoparticles." The patent coverage will include three main
methods of associating nanoparticles with filter media: (1) having pellets
of nanoparticles located adjacent to the filter media, (2) coating the
filter media with a powder of nanoparticles, and (3) impregnating the
nanoparticles into the filter media.
The Company already holds this broad patented protection in Australia,
India, New Zealand, Russia, Singapore and Taiwan and has active
applications encompassing 40+ countries around the world including the
United States. "This expansion of protected intellectual property
continues to increase the value of our overall portfolio and should build
shareholder value. The strategic advantage of this specific coverage as it
relates to potential licensee partnerships and nanotechnology enhanced
filtration product manufacturing is quite promising," said Thomas K. Allen,
President and CEO, ANI.
In addition, ANI continues to focus on U.S. patent efforts tied to its
NanoFense formulation, a proprietary antimicrobial nanoparticle filter
"coating." This technology development effort complements and bolsters all
of the issued patent coverage for many air filtration applications in some
of the most heavily populated regions of the world. "Our focused two-prong
approach to building a valuable and synergistic IP portfolio will directly
benefit potential licensees in all air filtration applications," stated Mr.
ANI is a marketer and developer of innovative nanotechnology-based air
filtration products specifically targeted to eradicate bacteria, virus and
fungi and is the owner of NEFT™ (Nanoparticle - Enhanced - Filtration -
Technology), a broad platform with significant application potential in
consumer and industrial market segments geared to reducing the transmission
of infectious pathogens.
For further information about Applied Nanoscience Inc., please visit:
Safe Harbor Statement
This release may contain statements that are forward-looking. Such
statements are made based upon current expectations that are subject to
risk and uncertainty. ANI does not undertake to update forward-looking
statements in this news release to reflect actual results of and changes in
assumptions or changes in other factors affecting such forward-looking
information. The actual future plans and results of the company could
differ significantly from such forward-looking statements.